Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers

Methods

Volumn 60, Issue 3, 2013, Pages 232-241

  Xiang, Sue D ^a   Wilson, Kirsty ^a   Day, Stephanie ^a   Fuchsberger, Martina ^a   Plebanski, Magdalena ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antibody; Antigen load; CD8; Inflammation; Nanoparticle; Vaccine

Indexed keywords

ANTIGEN; NANOPARTICLE; VACCINE;

ARTICLE; CD8+ T LYMPHOCYTE; CONJUGATION; IMMUNOGENICITY; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; IMMUNOCONJUGATES; MICE; NANOPARTICLES; PARTICLE SIZE; POLYSTYRENES; SHEEP; VACCINES, SYNTHETIC;

MUS; OVIS ARIES;

EID: 84878893034     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2013.03.036     Document Type: Article

References (31)

1. Kumari A., Yadav S.K., Yadav S.C. Colloids Surf. B 2010, 75:1-18.
2. Pinto Reis C., Neufeld R.J., Ribeiro A.J., Veiga F. Biol. Med. 2006, 2:8-21.
3. Cruz L.J., Rueda F., Cordobilla B., SimoÌn L., Hosta L., Albericio F., Domingo J.C. Mol. Pharm. 2009, 8:104-116.
4. Cruz L.J., Tacken P.J., Fokkink R., Figdor C.G. Biomaterials 2011, 32:6791-6803.
5. Fischer S., Uetz-von Allmen E., Waeckerle-Men Y., Groettrup M., Merkle H.P., Gander B. Biomaterials 2007, 28:994-1004.
6. Yoshida M., Babensee J.E. J. Biomed. Mater. Res. Part A 2004, 71A:45-54.
7. Faham A., Altin J.G. J. Immunol. 2010, 185:1744-1754.
8. Sjolander A., Cox J.C., Barr I.G. J. Leukoc. Biol. 1998, 64:713-723.
9. Wilkinson B.L., Day S., Chapman R., Perrier S., Apostolopoulos V., Payne R.J. Chemistry 2012, 18:16540-16548.
10. Didierlaurent A.M., Morel S., Lockman L., Giannini S.L., Bisteau M., Carlsen H., Kielland A., Vosters O., Vanderheyde N., Schiavetti F., Larocque D., Van Mechelen M., Garcon N. J. Immunol. 2009, 183:6186-6197.
11. Leroux-Roels G. Vaccine 2010, 28(Suppl. 3):C25-36.
12. Siegrist C.A., Pihlgren M., Tougne C., Efler S.M., Morris M.L., Aladhami M.J., Cameron D.W., Cooper C.L., Heathcote J., Davis H.L., Lambert P.H. Vaccine 2004, 23:615-622.
13. Steinhagen F., Kinjo T., Bode C., Klinman D.M. Vaccine 2011, 29:3341-3355.
14. Pelkmans L. Biochim. Biophys. Acta 2005, 1746:295-304.
15. Xiang S.D., Scholzen A., Minigo G., David C., Apostolopoulos V., Mottram P.L., Plebanski M. Methods 2006, 40:1-9.
16. Fifis T., Gamvrellis A., Crimeen-Irwin B., Pietersz G.A., Li J., Mottram P.L., McKenzie I.F., Plebanski M. J. Immunol. 2004, 173:3148-3154.
17. Fifis T., Mottram P., Bogdanoska V., Hanley J., Plebanski M. Vaccine 2004, 23:258-266.
18. Mottram P.L., Leong D., Crimeen-Irwin B., Gloster S., Xiang S.D., Meanger J., Ghildyal R., Vardaxis N., Plebanski M. Mol. Pharm. 2007, 4:73-84.
19. Xiang S.D., Kalkanidis M., Pietersz G.A., Mottram P.L., Crimeen-Irwin B., Ardipradja K., Plebanski M. Methods 2006, 40:20-29.
20. Scheerlinck J.P., Gloster S., Gamvrellis A., Mottram P.L., Plebanski M. Vaccine 2006, 24:1124-1131.
21. Foged C., Hansen J., Agger E.M. Pharm. Sci. 2012, 45:482-491.
22. Bevan M.J. J. Exp. Med. 1976, 143:1283-1288.
23. Villadangos J.A., Schnorrer P. Nat. Rev. Immunol. 2007, 7:543-555.
24. den Haan J.M., Lehar S.M., Bevan M.J. J. Exp. Med. 2000, 192:1685-1696.
25. Staros J.V., Wright R.W., Swingle D.M. Anal. Biochem. 1986, 156:220-222.
26. Erickson H.P. Biol. Proced. Online 2009, 11:32-51.
27. Webster T.J. Adv. Chem. Eng. 2001, 27:125-166.
28. Chen Y.S., Hung Y.C., Lin W.H., Huang G.S. Nanotechnology 2010, 21:195101.
29. Thomas C., Rawat A., Hope-Weeks L., Ahsan F. Mol. Pharm. 2011, 8:405-415.
30. Mann J.F., Shakir E., Carter K.C., Mullen A.B., Alexander J., Ferro V.A. Vaccine 2009, 27:3643-3649.
31. Bharat A., Benshoff N., Fleming T.P., Dietz J.R., Gillanders W.E., Mohanakumar T. Breast Cancer Res. Treat. 2008, 110:453-463.